Autor: Merkelbach, Matthias - Katalog zbiorów Biblioteki Wyższej Szkoły Bankowej we Wrocławiu

Skocz do pozycji: 1 1.

Tytuł :: Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications.
Autorzy :: Scheffler M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University of Cologne, Germany.
Wiesweg M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany; Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, Germany.
Michels S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University of Cologne, Germany.
Nogová L; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University of Cologne, Germany.
Kron A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University of Cologne, Germany.
Herold T; Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany.
Scheel AH; Faculty of Medicine and University Hospital Cologne, Institute of Pathology, University of Cologne, Germany.
Metzenmacher M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany; Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, Germany.
Eberhardt WE; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany; Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, Germany.
Reis H; Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany.
Fassunke J; Faculty of Medicine and University Hospital Cologne, Institute of Pathology, University of Cologne, Germany.
Darwiche K; Department of Pulmonary Medicine, Section of Interventional Pneumology, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, Germany.
Aigner C; Department of Thoracic Surgery and Endoscopy, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, Germany.
Schaufler D; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University of Cologne, Germany.
Riedel R; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University of Cologne, Germany.
Fischer R; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University of Cologne, Germany.
Koleczko S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University of Cologne, Germany.
Schildhaus HU; Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany.
Merkelbach-Bruse S; Faculty of Medicine and University Hospital Cologne, Institute of Pathology, University of Cologne, Germany.
Schmid KW; Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany.
Büttner R; Faculty of Medicine and University Hospital Cologne, Institute of Pathology, University of Cologne, Germany.
Wolf J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University of Cologne, Germany.
Schuler M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Germany; Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen - Ruhrlandklinik, University Duisburg-Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Germany. Electronic address: .; Pokaż więcej
Źródło :: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2022 Jun; Vol. 168, pp. 10-20. Date of Electronic Publication: 2022 Apr 16.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/pathology
ErbB Receptors/genetics ; Humans ; Mutation ; Prognosis ; Protein-Tyrosine Kinases/genetics ; Proto-Oncogene Proteins/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Reply to: "Survival Analysis of TP53 Co-Mutations Should be Interpreted More Cautiously".
Autorzy :: Saleh MM; Lung Cancer Group Cologne, Institute of Pathology, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
Scheffler M; Lung Cancer Group Cologne, Department I for Internal Medicine, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
Merkelbach-Bruse S; Lung Cancer Group Cologne, Institute of Pathology, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
Wolf J; Lung Cancer Group Cologne, Department I for Internal Medicine, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
Buettner R; Lung Cancer Group Cologne, Institute of Pathology and Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany. Electronic address: .; Pokaż więcej
Źródło :: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 Jun; Vol. 17 (6), pp. e57-e59.
Typ publikacji :: Letter; Comment
MeSH Terms :: Lung Neoplasms*/genetics
Humans ; Mutation ; Survival Analysis ; Tumor Suppressor Protein p53/genetics
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Comprehensive Analysis of TP53 and KEAP1 Mutations and Their Impact on Survival in Localized- and Advanced-Stage NSCLC.
Autorzy :: Saleh MM; Lung Cancer Group Cologne, Institute of Pathology, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
Scheffler M; Lung Cancer Group Cologne, Department I for Internal Medicine, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
Merkelbach-Bruse S; Lung Cancer Group Cologne, Institute of Pathology, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
Scheel AH; Lung Cancer Group Cologne, Institute of Pathology, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
Ulmer B; Lung Cancer Group Cologne, Institute of Pathology, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
Wolf J; Lung Cancer Group Cologne, Department I for Internal Medicine, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany.
Buettner R; Lung Cancer Group Cologne, Institute of Pathology, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, Cologne, Germany. Electronic address: .; Pokaż więcej
Źródło :: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 Jan; Vol. 17 (1), pp. 76-88. Date of Electronic Publication: 2021 Sep 30.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Kelch-Like ECH-Associated Protein 1*/genetics
Lung Neoplasms*/genetics
Tumor Suppressor Protein p53*/genetics
Carcinoma, Non-Small-Cell Lung/*genetics
Humans ; Mutation ; Prognosis ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer.
Autorzy :: Schaufler D; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Network Genomic Medicine, Lung Cancer Group Cologne, Cologne, Germany.
Ast DF; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Pathology, Molecular Pathology, Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany.; Mildred Scheel School of Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Tumbrink HL; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Pathology, Molecular Pathology, Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany.
Abedpour N; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne, Cologne, Germany.
Maas L; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany.
Schwäbe AE; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Pathology, Molecular Pathology, Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany.
Spille I; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Pathology, Molecular Pathology, Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany.
Lennartz S; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Pathology, Molecular Pathology, Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany.
Fassunke J; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Pathology, Network Genomic Medicine, Cologne, Germany.
Aldea M; Department of medical oncology, Thoracic Group, Gustave Roussy, Villejuif, Paris Sud University Orsay, Paris, France.
Besse B; Department of medical oncology, Thoracic Group, Gustave Roussy, Villejuif, Paris Sud University Orsay, Paris, France.
Planchard D; Department of medical oncology, Thoracic Group, Gustave Roussy, Villejuif, Paris Sud University Orsay, Paris, France.
Nogova L; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Network Genomic Medicine, Lung Cancer Group Cologne, Cologne, Germany.
Michels S; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Network Genomic Medicine, Lung Cancer Group Cologne, Cologne, Germany.
Kobe C; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Nuclear Medicine, Cologne, Germany.
Persigehl T; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Diagnostic and Interventional Radiology, Cologne, Germany.
Westphal T; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Network Genomic Medicine, Lung Cancer Group Cologne, Cologne, Germany.
Koleczko S; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Network Genomic Medicine, Lung Cancer Group Cologne, Cologne, Germany.
Fischer R; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Network Genomic Medicine, Lung Cancer Group Cologne, Cologne, Germany.
Weber JP; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Network Genomic Medicine, Lung Cancer Group Cologne, Cologne, Germany.
Altmüller J; Cologne Center for Genomics, University of Cologne, Cologne, Germany.
Thomas RK; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Pathology, Network Genomic Medicine, Cologne, Germany.; DKFZ, German Cancer Research Center, German Cancer Consortium (DKTK), Heidelberg, Germany.
Merkelbach-Bruse S; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Pathology, Network Genomic Medicine, Cologne, Germany.
Gautschi O; University of Bern and Cantonal Hospital of Lucerne, Lucerne, Switzerland.
Mezquita L; Medical Oncology Department, Hospital Clinic, Laboratory of Translational Genomics and Targeted therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.
Büttner R; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Pathology, Network Genomic Medicine, Cologne, Germany.
Wolf J; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Network Genomic Medicine, Lung Cancer Group Cologne, Cologne, Germany.
Peifer M; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany.
Brägelmann J; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Pathology, Molecular Pathology, Cologne, Germany. .; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany. .; Mildred Scheel School of Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. .; University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne, Cologne, Germany. .
Scheffler M; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Network Genomic Medicine, Lung Cancer Group Cologne, Cologne, Germany. matthias..
Sos ML; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Pathology, Molecular Pathology, Cologne, Germany. .; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany. .; University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne, Cologne, Germany. .; Pokaż więcej
Źródło :: NPJ precision oncology [NPJ Precis Oncol] 2021 Dec 17; Vol. 5 (1), pp. 102. Date of Electronic Publication: 2021 Dec 17.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer
Autorzy :: Diana Schaufler
David F. Ast
Hannah L. Tumbrink
Nima Abedpour
Lukas Maas
Ayla E. Schwäbe
Inga Spille
Stefanie Lennartz
Jana Fassunke
Mihaela Aldea
Benjamin Besse
David Planchard
Lucia Nogova
Sebastian Michels
Carsten Kobe
Thorsten Persigehl
Theresa Westphal
Sophia Koleczko
Rieke Fischer
Jan-Phillip Weber
Janine Altmüller
Roman K. Thomas
Sabine Merkelbach-Bruse
Oliver Gautschi
Laura Mezquita
Reinhard Büttner
Jürgen Wolf
Martin Peifer
Johannes Brägelmann
Matthias Scheffler
Martin L. Sos; Pokaż więcej
Temat :: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło :: npj Precision Oncology, Vol 5, Iss 1, Pp 1-12 (2021)
Opis pliku :: electronic resource
Relacje :: https://doaj.org/toc/2397-768X
Dostęp URL :: https://doaj.org/article/2fe94ce5763c49248add719a2c82fe60
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy
Autorzy :: Thelen, Martin
Wennhold, Kerstin
Lehmann, Jonas
Garcia-Marquez, Maria
Klein, SebastianAff2, Aff3
Kochen, Elena
Lohneis, Philipp
Lechner, Axel
Wagener-Ryczek, Svenja
Plum, Patrick SvenAff2, Aff3, Aff5
Velazquez Camacho, Oscar
Pfister, David
Dörr, Fabian
Heldwein, Matthias
Hekmat, Khosro
Beutner, Dirk
Klussmann, Jens Peter
Thangarajah, Fabinshy
Ratiu, Dominik
Malter, Wolfram
Merkelbach-Bruse, Sabine
Bruns, Christiane JosephineAff1, Aff5
Quaas, Alexander
von Bergwelt-Baildon, MichaelAff1, Aff11, Aff12
Schlößer, Hans A.Aff1, Aff5; Pokaż więcej
Źródło :: npj Precision Oncology. 5(1)
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Comprehensive Analysis of TP53 and KEAP1 Mutations and Their Impact on Survival in Localized- and Advanced-Stage NSCLC
Autorzy :: Mohamed Mahde Saleh
Matthias Scheffler
Sabine Merkelbach-Bruse
Andreas Hans Scheel
Bastian Ulmer
Jürgen Wolf
Reinhard Buettner; Pokaż więcej
Temat :: Pulmonary and Respiratory Medicine
Oncology
Źródło :: Journal of Thoracic Oncology.
Dostępność :: https://explore.openaire.eu/search/publication?articleId=doi_________::2d6d7924f1ef5b82c0a8ec5b6e621581
https://api.elsevier.com/content/article/PII:S1556086421031877?httpAccept=text/xml

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy
Autorzy :: Martin Thelen
Kerstin Wennhold
Jonas Lehmann
Maria Garcia-Marquez
Sebastian Klein
Elena Kochen
Philipp Lohneis
Axel Lechner
Svenja Wagener-Ryczek
Patrick Sven Plum
Oscar Velazquez Camacho
David Pfister
Fabian Dörr
Matthias Heldwein
Khosro Hekmat
Dirk Beutner
Jens Peter Klussmann
Fabinshy Thangarajah
Dominik Ratiu
Wolfram Malter
Sabine Merkelbach-Bruse
Christiane Josephine Bruns
Alexander Quaas
Michael von Bergwelt-Baildon
Hans A. Schlößer; Pokaż więcej
Temat :: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Article
Immunoediting
Cancer immunotherapy
Źródło :: npj Precision Oncology, Vol 5, Iss 1, Pp 1-12 (2021)
NPJ Precision Oncology
Dostępność :: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3892e0783bc95867ab723a0eed7ebb1e
https://doaj.org/article/4edee7d56ead4b1585567524e79d56a7

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study
Autorzy :: Bauerle, Michael
Besselmann, Michael
Büttner, T
Dem, Petra
Diekmann, Jens
Dietzel, Joanna
Dziewas, Rainer
Ehrlich, Sven
Evens, Annette
Gahn, Georg
Günther, Albrecht
Hamann, Gerhard F
Hartmann, Andreas
Harvey, Karen Louise
Heidenreich, Fedor
Helberg, T
Hobohm, Carsten
Hoffmann, F
Hoffmann, Olaf
Jungehulsing, Gerhard J
Kampschulte, Eva-Maria
Kraft, Peter
Krogias, Christos
Leinisch, Elke
Maschke, Matthias
Merkelbach, Stefan
Muehler, Johannes
Niehaus, Ludwig
Nören, Gesa
Oschmann, P
Palm, Frederick
Petzold, Gabor C
Pfeiler, Larissa
Pfeilschifter, Waltraud
Prince, Marie
Ringleb, Peter
Rosenkranz, Michael
Royl, Georg
Schnabel, Renate B
Schurig, Johannes
Steinbrecher, A
Stingele, Robert
Tanislav, Christian
Tyler, Louise
Urbanek, Christian
Haeusler, Karl Georg; Pokaż więcej
Źródło :: In The Lancet Neurology June 2021 20(6):426-436
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: KEAP1 mutations in squamous cell lung cancer
Autorzy :: Sophia Koleczko
Axel Hillmer
Abdel Hakim Bayarassou
Christian Grohé
Martin Buchenroth
Britta Kaminsky
Clemens Schulte
Sebastian Yves Friedrich Michels
Diana Schaufler
Anna Kron
Richard Riedel
Theresa Westphal
Jan-Phillip Weber
Rieke Nila Fischer
Sabine Merkelbach-Bruse
Lucia Nogova
Reinhard Buettner
Juergen Wolf
Matthias Scheffler; Pokaż więcej
Temat :: Cancer Research
Oncology
Źródło :: Journal of Clinical Oncology. 39:e21098-e21098
Dostępność :: https://explore.openaire.eu/search/publication?articleId=doi_________::44e82f22f1992a4a664c1a32c717c2ac

Szczegóły

Skocz do pozycji: 11 11.

Informacja :: Dostęp do tej pozycji wymaga zalogowania się.
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of Immunotherapy.
Autorzy :: Kron A; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Scheffler M; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Heydt C; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Ruge L; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Schaepers C; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Eisert AK; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Merkelbach-Bruse S; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Riedel R; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Nogova L; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Fischer RN; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Michels S; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Abdulla DSY; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Koleczko S; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Fassunke J; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Schultheis AM; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Kron F; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany; FOM University of Applied Sciences, Essen, Germany.
Ueckeroth F; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Wessling G; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Sueptitz J; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Beckers F; Network Genomic Medicine, Cologne, Germany; Department of Thoracic Surgery, St. Vinzenz-Hospital Cologne, Cologne, Germany.
Braess J; Network Genomic Medicine, Cologne, Germany; Department of Hematology and Oncology, Hospital Barmherzige Brueder Regensburg, Regensburg, Germany.
Panse J; Network Genomic Medicine, Cologne, Germany; Department of Internal Medicine IV, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital RWTH Aachen, Aachen, Germany.
Grohé C; Network Genomic Medicine, Cologne, Germany; Department of Pneumology, Evangelische Lungenklinik Berlin, Berlin, Germany.
Hamm M; Network Genomic Medicine, Cologne, Germany; Department of Pneumology and Respiratory Medicine, Helios Medical Center of Hildesheim, Hildesheim, Germany.
Kabitz HJ; Network Genomic Medicine, Cologne, Germany; Department of Internal Medicine II, Clinic of Konstanz, Konstanz, Germany.
Kambartel K; Network Genomic Medicine, Cologne, Germany; Department of Thoracic Oncology and Interventional Bronchology, Hospital Bethanien Moers, Moers, Germany.
Kaminsky B; Network Genomic Medicine, Cologne, Germany; Department of Pneumonology and Allergology, Hospital Bethanien Solingen, Solingen, Germany.
Krueger S; Network Genomic Medicine, Cologne, Germany; Department of Pneumonology, Florence-Nightingale Hospital Düsseldorf, Düsseldorf, Germany.
Schulte C; Network Genomic Medicine, Cologne, Germany; Joint Private Practice for Hematology/Oncology, Dortmund, Germany.
Lorenz J; Network Genomic Medicine, Cologne, Germany; Department of Pneumology, Hospital Luedenscheid, Luedenscheid, Germany.
Lorenzen J; Network Genomic Medicine, Cologne, Germany; Department of Pathology, Hospital Dortmund, Dortmund, Germany.
Meister W; Network Genomic Medicine, Cologne, Germany; Department of Thoracic Oncology and Interventional Bronchology, Helios Medical Center of Hildesheim, Hildesheim, Germany.
Meyer A; Network Genomic Medicine, Cologne, Germany; Department of Pulmonary Medicine, Maria Hilf Hospital GmbH, Moenchengladbach, Germany.
Kappes J; Network Genomic Medicine, Cologne, Germany; Department of Internal Medicine and Pneumology, Catholic Hospital Koblenz, Koblenz, Germany.
Reinmuth N; Network Genomic Medicine, Cologne, Germany; Department of Oncology, Asklepios Clinic Munich-Gauting, Munich-Gauting, Germany.
Schaaf B; Network Genomic Medicine, Cologne, Germany; Department of Respiratory Medicine and Infectious Diseases, Medical Center North of Dortmund, Dortmund, Germany.
Schulte W; Network Genomic Medicine, Cologne, Germany; Department of Pneumology and Allergology, GFO Clinic Bonn, Bonn, Germany.
Serke M; Network Genomic Medicine, Cologne, Germany; Department of Pneumology and Oncology, Evangelic Hospital Hamm, Hamm, Germany.
Buettner R; Network Genomic Medicine, Cologne, Germany; Institute of Pathology, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany.
Wolf J; Network Genomic Medicine, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Cologne, Germany. Electronic address: .; Pokaż więcej
Źródło :: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2021 Apr; Vol. 16 (4), pp. 572-582. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :: Journal Article
MeSH Terms :: Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Genetic Heterogeneity ; Humans ; Immunotherapy ; In Situ Hybridization, Fluorescence ; Mutation ; Proto-Oncogene Proteins c-met/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Detection of circulating tumor DNA by digital droplet PCR in resectable lung cancer as a predictive tool for recurrence.
Autorzy :: Gassa A; Department of Cardiothoracic Surgery, University of Cologne, Germany; Department of General, Visceral, and Cancer Surgery, University of Cologne, Germany. Electronic address: .
Fassunke J; Institute of Pathology, University of Cologne, Germany.
Schueten S; Department of Cardiothoracic Surgery, University of Cologne, Germany; Department of General, Visceral, and Cancer Surgery, University of Cologne, Germany; School of Medicine, University of Cologne, Germany.
Kuhlmann L; Department of Cardiothoracic Surgery, University of Cologne, Germany; Department of General, Visceral, and Cancer Surgery, University of Cologne, Germany; School of Medicine, University of Cologne, Germany.
Scherer M; Department of General, Visceral, and Cancer Surgery, University of Cologne, Germany; School of Medicine, University of Cologne, Germany.
Qien J; Department of General, Visceral, and Cancer Surgery, University of Cologne, Germany.
Zhao Y; Department of General, Visceral, and Cancer Surgery, University of Cologne, Germany.
Michel M; Institute of Zoology, University of Cologne, Germany.
Loeser H; Institute of Pathology, University of Cologne, Germany.
Wolf J; Department of Internal Medicine I, University of Cologne, Germany.
Buettner R; Institute of Pathology, University of Cologne, Germany.
Doerr F; Department of Cardiothoracic Surgery, University of Cologne, Germany.
Heldwein M; Department of Cardiothoracic Surgery, University of Cologne, Germany.
Hagmeyer L; Hospital Bethanien Solingen, Institute of Pneumology, University of Cologne, Solingen, Germany.
Frank K; Department of Internal Medicine III, University of Cologne, Germany.
Merkelbach-Bruse S; Institute of Pathology, University of Cologne, Germany.
Quaas A; Institute of Pathology, University of Cologne, Germany.
Bruns C; Department of General, Visceral, and Cancer Surgery, University of Cologne, Germany.
Hekmat K; Department of Cardiothoracic Surgery, University of Cologne, Germany.
Weiss J; Department of Internal Medicine I, University of Cologne, Germany.
Wahlers T; Department of Cardiothoracic Surgery, University of Cologne, Germany.
Alakus H; Department of General, Visceral, and Cancer Surgery, University of Cologne, Germany.; Pokaż więcej
Źródło :: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2021 Jan; Vol. 151, pp. 91-96. Date of Electronic Publication: 2020 Nov 05.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Circulating Tumor DNA*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Neoplasm Recurrence, Local*/genetics
Biomarkers, Tumor/genetics ; High-Throughput Nucleotide Sequencing ; Humans ; Mutation ; Polymerase Chain Reaction ; Prospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of Immunotherapy
Autorzy :: Jürgen Wolf
Joachim Lorenz
Anna-Kristina Eisert
Richard F. Riedel
Stefan Krueger
Andreas Meyer
Wolfgang Schulte
Matthias Scheffler
Hans-Joachim Kabitz
Carsten Schaepers
Sabine Merkelbach-Bruse
Jana Fassunke
Anne M. Schultheis
Britta Kaminsky
Lucia Nogova
Gabriele Wessling
Diana S.Y. Abdulla
Reinhard Buettner
Wolfram Meister
Sebastian Michels
Frank Ueckeroth
Florian Kron
Johann Lorenzen
Sophia Koleczko
Frank Beckers
Anna Kron
Kato Kambartel
Carina Heydt
Niels Reinmuth
Michael Hamm
Juliane Sueptitz
Rieke Fischer
Monika Serke
Bernhard Schaaf
Lea Ruge
Christian Grohé
Jutta Kappes
Clemens Schulte
Jens Panse
Jan Braess; Pokaż więcej
Temat :: Pulmonary and Respiratory Medicine
Oncology
Cancer research
Genetic heterogeneity
Immunohistochemistry
Lung cancer
medicine.disease
medicine
business.industry
business
Non small cell
Copy-number variation
Immunotherapy
medicine.medical_treatment
MET Exon 14 Mutation
Overall survival
Źródło :: Journal of Thoracic Oncology. 16:572-582
Dostępność :: https://explore.openaire.eu/search/publication?articleId=doi_________::bc23f7e85f05f773a1ed2d4bef0e7c16
https://api.elsevier.com/content/article/PII:S1556086420310911?httpAccept=text/xml

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Detection of circulating tumor DNA by digital droplet PCR in resectable lung cancer as a predictive tool for recurrence
Autorzy :: Hakan Alakus
Fabian Doerr
Reinhard Buettner
Alexander Quaas
Christiane Bruns
Asmae Gassa
Marie Scherer
Juergen Wolf
Jie Qien
Max Michel
Khosro Hekmat
Lars Hagmeyer
Sabine Merkelbach-Bruse
Heike Loeser
Thorsten Wahlers
Yue Zhao
Konrad Frank
Jana Fassunke
Matthias Heldwein
Luca Kuhlmann
Sarah Schueten
Jonathan Weiss; Pokaż więcej
Temat :: Cancer Research
Pulmonary and Respiratory Medicine
Oncology
Medicine
business.industry
business
Prospective cohort study
Internal medicine
medicine.medical_specialty
Primary tumor
medicine.disease
Lung cancer
Stage (cooking)
Cell-free fetal DNA
Germline mutation
Liquid biopsy
Mutation
medicine.disease_cause
Źródło :: Lung Cancer. 151:91-96
Dostępność :: https://explore.openaire.eu/search/publication?articleId=doi_________::b46fa07072e5fcdd9444a4469cc88beb
https://api.elsevier.com/content/article/PII:S016950022030670X?httpAccept=text/xml

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Was die neuen Kriterien für die Institute bedeuten. (German)
Autorzy :: Merkelbach, Matthias
Hören, Martin von; Pokaż więcej
Źródło :: Die Bank; 2020, Issue 10, p48-51, 4p
: Periodyk

Szczegóły Pełny tekst

Skocz do pozycji: 17 17.

Tytuł :: Abstract CT255: EATON: A phase I dose-escalation trial of nazartinib (EGF816) and trametinib in EGFR-mutant NSCLC
Autorzy :: Barbara Deschler-Baier
Enriqueta Felip
Richard F. Riedel
Martin Schuler
Matthias Scheffler
Lucia Nogova
Sebastian Michels
Diana S.Y. Abdulla
Sabine Merkelbach-Bruse
Martin Hellmich
Jan-Philipp Weber
Martin Sebastian
Anna Kron
Delvys Rodriguez Abreu
Jürgen Wolf
Jana Fassunke
Sophia Koleczko
Reinhard Büttner
Rieke Fischer
Rafael Rosell
Heinz Haverkammp
Martin Wermke; Pokaż więcej
Temat :: Oncology
medicine.medical_specialty
medicine
Cancer
medicine.disease
Osimertinib
Rash
medicine.symptom
Adverse effect
Lung cancer
Progressive disease
Trametinib
business.industry
business
Anemia
Internal medicine
Źródło :: Tumor Biology.
Dostępność :: https://explore.openaire.eu/search/publication?articleId=doi_________::073fe33e325b5c48581c2f86ffd34912
https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2020-CT255

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays.
Autorzy :: Kirchner M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Glade J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Lehmann U; Institute of Pathology, University Hospital Hannover, Hannover, Germany.
Merkelbach-Bruse S; Institute of Pathology, University Hospital Cologne, Cologne, Germany.
Hummel M; Institute of Pathology, Charité University Hospital, Berlin, Germany.
Lehmann A; Institute of Pathology, Charité University Hospital, Berlin, Germany.
Trautmann M; Institute of Pathology, University Hospital Münster, Münster, Germany.
Kumbrink J; Institute of Pathology, Ludwig Maximilian University (LMU), Munich, Germany.
Jung A; Institute of Pathology, Ludwig Maximilian University (LMU), Munich, Germany.
Dietmaier W; Institute of Pathology, University Hospital Regensburg, Regensburg, Germany.
Endris V; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Kazdal D; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Ploeger C; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Evert M; Institute of Pathology, University Hospital Regensburg, Regensburg, Germany.
Horst D; Institute of Pathology, Charité University Hospital, Berlin, Germany.
Kreipe H; Institute of Pathology, University Hospital Hannover, Hannover, Germany.
Kirchner T; Institute of Pathology, Ludwig Maximilian University (LMU), Munich, Germany.
Wardelmann E; Institute of Pathology, University Hospital Münster, Münster, Germany.
Büttner R; Institute of Pathology, University Hospital Cologne, Cologne, Germany.
Weichert W; Institute of Pathology, Technical University Munich (TUM), Munich, Germany.
Dietel M; Institute of Pathology, Charité University Hospital, Berlin, Germany.; Quality Assurance Initiative in Pathology (QuiP), Berlin, Germany.
Schirmacher P; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Pfarr N; Institute of Pathology, Technical University Munich (TUM), Munich, Germany.; Pokaż więcej
Źródło :: Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2020 Aug; Vol. 59 (8), pp. 445-453. Date of Electronic Publication: 2020 May 09.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Biomarkers, Tumor/*genetics
Genetic Testing/*methods
Neoplasms/*genetics
Oncogene Proteins, Fusion/*genetics
RNA-Seq/*methods
Receptor Tyrosine Kinase-like Orphan Receptors/*genetics
Genetic Testing/standards ; Humans ; In Situ Hybridization, Fluorescence/methods ; Neoplasms/diagnosis ; RNA-Seq/standards ; Sensitivity and Specificity ; Tissue Preservation/methods
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment.
Autorzy :: Nogova, Lucia
Mattonet, Christian
Scheffler, Matthias
Taubert, Max
Gardizi, Masyar
Sos, Martin L.
Michels, Sebastian
Fischer, Rieke N.
Limburg, Meike
Abdulla, Diana S.Y.
Persigehl, Thorsten
Kobe, Carsten
Merkelbach‐Bruse, Sabine
Franklin, Jeremy
Backes, Heiko
Schnell, Roland
Behringer, Dirk
Kaminsky, Britta
Eichstaedt, Martina
Stelzer, Christoph; Pokaż więcej
Temat :: NON-small-cell lung carcinoma
PROGRESSION-free survival
SORAFENIB
EVEROLIMUS
TUMORS
Źródło :: Cancer Medicine; Jul2020, Vol. 9 Issue 14, p4991-5007, 17p
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 20 20.

Tytuł :: Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study.
Autorzy :: Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany. Electronic address: .
Endris V; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Budczies J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Merkelbach-Bruse S; Institute of Pathology, University Hospital Cologne, Cologne, Germany.
Kazdal D; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
Dietmaier W; Institute of Pathology, University Regensburg, Regensburg, Germany.
Pfarr N; Institute of Pathology, Technical University Munich (TUM), Munich, Germany.
Siebolts U; Institute of Pathology, University Hospital Halle, Halle, Germany.
Hummel M; Institute of Pathology, Charité University Hospital, Berlin, Germany.
Herold S; Institute of Pathology, University Hospital Dresden, Dresden, Germany.
Andreas J; Institute of Hematopathology, Hamburg, Germany.
Zoche M; Institute of Pathology, University Hospital Zurich, Zurich, Switzerland.
Tögel L; Institute of Pathology, University Hospital Erlangen, Erlangen, Germany.
Rempel E; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Maas J; Quality in Pathology (QuIP), Berlin, Germany.
Merino D; Friends of Cancer Research (FoCR), Washington, District of Columbia.
Stewart M; Friends of Cancer Research (FoCR), Washington, District of Columbia.
Zaoui K; Department of Otorhinolaryngology, University Hospital Heidelberg, Heidelberg, Germany.
Schlesner M; Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Glimm H; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT Dresden) and University Hospital Carl Gustav Carus, Dresden, and Translational Functional Cancer Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), Dresden, Germany.
Fröhling S; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Allen J; Friends of Cancer Research (FoCR), Washington, District of Columbia.
Horst D; Institute of Pathology, Charité University Hospital, Berlin, Germany.
Baretton G; Institute of Pathology, University Hospital Dresden, Dresden, Germany.
Wickenhauser C; Institute of Pathology, University Hospital Halle, Halle, Germany.
Tiemann M; Institute of Hematopathology, Hamburg, Germany.
Evert M; Institute of Pathology, University Regensburg, Regensburg, Germany.
Moch H; Institute of Pathology, University Hospital Zurich, Zurich, Switzerland.
Kirchner T; Institute of Pathology, Ludwig-Maximilians University (LMU), Munich, Germany.
Büttner R; Institute of Pathology, University Hospital Cologne, Cologne, Germany.
Schirmacher P; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Jung A; Institute of Pathology, Ludwig-Maximilians University (LMU), Munich, Germany.
Haller F; Institute of Pathology, University Hospital Erlangen, Erlangen, Germany.
Weichert W; Institute of Pathology, Technical University Munich (TUM), Munich, Germany.
Dietel M; Quality in Pathology (QuIP), Berlin, Germany.; Pokaż więcej
Źródło :: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2020 Jul; Vol. 15 (7), pp. 1177-1189. Date of Electronic Publication: 2020 Feb 29.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Lung Neoplasms*/genetics
Biomarkers, Tumor/genetics ; Humans ; Mutation ; Reference Standards ; Whole Exome Sequencing
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaBiblioteka WSB we Wrocławiu

Wyszukujesz frazę "Merkelbach, Matthias" wg kryterium: Autor

Źródło danych

Ogranicz do:

Dostawca treści

Typ dokumentu

Temat

Wydawca

Publikacja

Język